The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Roles of BCL6 in normal and transformed germinal center B cells
Abstract
Summary: BCL6 is a transcriptional repressor required in mature B cells during the germinal center (GC) reaction. Multiple mechanisms act coordinately to timely modulate BCL6 expression at transcriptional and post‐transcriptional levels. BCL6 prevents premature activation and differentiation of GC B cells and provides an environment tolerant of the DNA breaks associated with immunoglobulin gene remodeling mechanisms involved in the production of high‐affinity antibodies of different isotypes. The critical functions exerted by BCL6 during normal B‐cell development can be hijacked by the malignant transformation process. Indeed, BCL6 is targeted by genetic aberrations and acts as an oncogene in GC‐derived lymphomas. The aberrations affecting BCL6 interfere with the multiple levels of regulation that grant a fine tuning of BCL6 expression and activity in physiologic conditions. This review summarizes the current knowledge on BCL6 function and its role in lymphomagenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., et al. (2000) · Nature · doi:10.1038/35000501 · Cited by 9,925
PD-1 and Its Ligands in Tolerance and Immunity
Keir, M. E., Butte, M. J., Freeman, G. J., & Sharpe, A. H. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090331 · Cited by 5,378 · cited 1×
“and inhibition of the T-cell response (40).”
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559
Johnston, R. J., Poholek, A. C., DiToro, D., Yusuf, I., Eto, D., Barnett, B., Dent, A. L., Craft, J., & Crotty, S. (2009) · Science · doi:10.1126/science.1175870 · Cited by 1,626
Kruse, J.-P., & Gu, W. (2009) · Cell · doi:10.1016/j.cell.2009.04.050 · Cited by 1,610 · cited 1×
“Two distinct pathways are involved in acetylationmediated activation of TP53, as shown by the activity of the class I and II histone deacetylase (HDAC) inhibitor trichostatin A (TSA) and class III histone deacetylase or sirtuin inhibitor nicotinamide (NIA) in enforcing TP53 activity (59, 60).”
BackgroundBcl6 mediates the development of T follicular helper cells
Nurieva, R. I., Chung, Y., Martinez, G. J., Yang, X. O., Tanaka, S., Matskevitch, T. D., Wang, Y.-H., & Dong, C. (2009) · Science · doi:10.1126/science.1176676 · Cited by 1,506
The Transcriptional Repressor Bcl-6 Directs T Follicular Helper Cell Lineage Commitment
Yu, D., Rao, S., Tsai, L. M., Lee, S. K., He, Y., Sutcliffe, E. L., Srivastava, M., Linterman, M., Zheng, L., Simpson, N., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.07.002 · Cited by 1,228
Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP
Petrif, F., Giles, R. H., Dauwerse, H. G., Saris, J. J., Hennekam, R. C. M., Masuno, M., Tommerup, N., van Ommen, G.-J. B., Goodman, R. H., Peters, D. J. M., et al. (1995) · Nature · doi:10.1038/376348a0 · Cited by 1,217 · cited 1×
“suppressor genes, a notion supported by the observation that the Rubinstein–Taybi syndrome, an autosomal congenital disorder due to haploinsufficency of CREBBP or EP300, is associated with predisposition to the development of tumors including lymphomas (71, 72).”
BackgroundInactivating mutations of acetyltransferase genes in B-cell lymphoma
Pasqualucci, L., Dominguez-Sola, D., Chiarenza, A., Fabbri, G., Grunn, A., Trifonov, V., Kasper, L. H., Lerach, S., Tang, H., Ma, J., et al. (2011) · Nature · doi:10.1038/nature09730 · Cited by 949
Self-citationShapiro-Shelef, M., Lin, K.-I., McHeyzer-Williams, L. J., Liao, J., McHeyzer-Williams, M. G., & Calame, K. (2003) · Immunity · doi:10.1016/s1074-7613(03)00267-x · Cited by 839
Monti, S. (2005) · Blood · doi:10.1182/blood-2004-07-2947 · Cited by 820
Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination
Klein, U., Casola, S., Cattoretti, G., Shen, Q., Lia, M., Mo, T., Ludwig, T., Rajewsky, K., & Dalla-Favera, R. (2006) · Nature Immunology · doi:10.1038/ni1357 · Cited by 801
Self-citationControl of B-cell responses by Toll-like receptors
Pasare, C., & Medzhitov, R. (2005) · Nature · doi:10.1038/nature04267 · Cited by 752
Shaffer, A. L., Yu, X., He, Y., Boldrick, J., Chan, E. P., & Staudt, L. M. (2000) · Immunity · doi:10.1016/s1074-7613(00)00020-0 · Cited by 724
Alterations of a Zinc Finger-Encoding Gene, BCL-6 , in Diffuse Large-Cell Lymphoma
Ye, B. H., Lista, F., Lo Coco, F., Knowles, D. M., Offit, K., Chaganti, R. S. K., & Dalla-Favera, R. (1993) · Science · doi:10.1126/science.8235596 · Cited by 683
Self-citationThe BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells
Phan, R. T., & Dalla-Favera, R. (2004) · Nature · doi:10.1038/nature03147 · Cited by 679
Self-citationSciammas, R., Shaffer, A. L., Schatz, J. H., Zhao, H., Staudt, L. M., & Singh, H. (2006) · Immunity · doi:10.1016/j.immuni.2006.07.009 · Cited by 571
Pasqualucci, L., Migliazza, A., Fracchiolla, N., William, C., Neri, A., Baldini, L., Chaganti, R. S. K., Klein, U., Küppers, R., Rajewsky, K., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11816 · Cited by 536
Self-citationMutation of BCL-6 Gene in Normal B Cells by the Process of Somatic Hypermutation of Ig Genes
Shen, H. M., Peters, A., Baron, B., Zhu, X., & Storb, U. (1998) · Science · doi:10.1126/science.280.5370.1750 · Cited by 531
Borriello, F., Sethna, M. P., Boyd, S. D., Schweitzer, A. N., Tivol, E. A., Jacoby, D., Strom, T. B., Simpson, E. M., Freeman, G. J., & Sharpe, A. H. (1997) · Immunity · doi:10.1016/s1074-7613(00)80333-7 · Cited by 498
Kerfoot, S. M., Yaari, G., Patel, J. R., Johnson, K. L., Gonzalez, D. G., Kleinstein, S. H., & Haberman, A. M. (2011) · Immunity · doi:10.1016/j.immuni.2011.03.024 · Cited by 491
BCoR, a novel corepressor involved in BCL-6 repression
Huynh, K. D., Fischle, W., Verdin, E., & Bardwell, V. J. (2000) · Genes & Development · doi:10.1101/gad.14.14.1810 · Cited by 477
Falini, B., Fizzotti, M., Pucciarini, A., Bigerna, B., Marafioti, T., Gambacorta, M., Pacini, R., Alunni, C., Natali–Tanci, L., Ugolini, B., et al. (2000) · Blood · doi:10.1182/blood.v95.6.2084 · Cited by 475
Self-citationTGF-β Receptor Controls B Cell Responsiveness and Induction of IgA In Vivo
Cazac, B. B., & Roes, J. (2000) · Immunity · doi:10.1016/s1074-7613(00)00044-3 · Cited by 429
Kerckaert, J.-P., Deweindt, C., Tilly, H., Quief, S., Lecocq, G., & Bastard, C. (1993) · Nature Genetics · doi:10.1038/ng0993-66 · Cited by 427
BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor.
Chang, C. C., Ye, B. H., Chaganti, R. S., & Dalla-Favera, R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.6947 · Cited by 424
Self-citationThe prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults
Zacchi, P., Gostissa, M., Uchida, T., Salvagno, C., Avolio, F., Volinia, S., Ronai, Z., Blandino, G., Schneider, C., & Sal, G. D. (2002) · Nature · doi:10.1038/nature01120 · Cited by 414
Kitano, M., Moriyama, S., Ando, Y., Hikida, M., Mori, Y., Kurosaki, T., & Okada, T. (2011) · Immunity · doi:10.1016/j.immuni.2011.03.025 · Cited by 411
Transcriptional analysis of the B cell germinal center reaction
Klein, U., Tu, Y., Stolovitzky, G. A., Keller, J. L., Haddad, J., Miljkovic, V., Cattoretti, G., Califano, A., & Dalla-Favera, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0437996100 · Cited by 409
Self-citationAcetylation inactivates the transcriptional repressor BCL6
Bereshchenko, O. R., Gu, W., & Dalla-Favera, R. (2002) · Nature Genetics · doi:10.1038/ng1018 · Cited by 394
Self-citationSaito, M., Gao, J., Basso, K., Kitagawa, Y., Smith, P. M., Bhagat, G., Pernis, A., Pasqualucci, L., & Dalla-Favera, R. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.08.011 · Cited by 387
Self-citationCattoretti, G., Pasqualucci, L., Ballon, G., Tam, W., Nandula, S. V., Shen, Q., Mo, T., Murty, V. V., & Dalla-Favera, R. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.03.037 · Cited by 383 · cited 1×
“Indeed, these mice displayed BCL6 deregulated expression leading to the development of lymphomas with most of the characteristic of human DLBCL, including a diffuse histologic pattern, a mature B-cell immune-phenotype, and hypermutated Ig genes indicating an origin from GC or post-GC B cells (74).”
BackgroundSelf-citationThe prolyl isomerase Pin1 is a regulator of p53 in genotoxic response
Zheng, H., You, H., Zhou, X. Z., Murray, S. A., Uchida, T., Wulf, G., Gu, L., Tang, X., Lu, K. P., & Xiao, Z.-X. J. (2002) · Nature · doi:10.1038/nature01116 · Cited by 383
Direct Repression of prdm1 by Bcl-6 Inhibits Plasmacytic Differentiation
Tunyaplin, C., Shaffer, A. L., Angelin-Duclos, C. D., Yu, X., Staudt, L. M., & Calame, K. L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.1158 · Cited by 376
AID is required for germinal center–derived lymphomagenesis
Pasqualucci, L., Bhagat, G., Jankovic, M., Compagno, M., Smith, P., Muramatsu, M., Honjo, T., Morse, H. C., Nussenzweig, M. C., & Dalla-Favera, R. (2008) · Nature Genetics · doi:10.1038/ng.2007.35 · Cited by 376
Self-citationPhan, R. T., Saito, M., Basso, K., Niu, H., & Dalla-Favera, R. (2005) · Nature Immunology · doi:10.1038/ni1245 · Cited by 343
Self-citationCommitment of B Lymphocytes to a Plasma Cell Fate Is Associated with Blimp-1 Expression In Vivo
Angelin-Duclos, C., Cattoretti, G., Lin, K.-I., & Calame, K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.10.5462 · Cited by 337
Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein
Dhordain, P., Albagli, O., Lin, R. J., Ansieau, S., Quief, S., Leutz, A., Kerckaert, J.-P., Evans, R. M., & Leprince, D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10762 · Cited by 334
MTA3 and the Mi-2/NuRD Complex Regulate Cell Fate during B Lymphocyte Differentiation
Fujita, N., Jaye, D. L., Geigerman, C., Akyildiz, A., Mooney, M. R., Boss, J. M., & Wade, P. A. (2004) · Cell · doi:10.1016/j.cell.2004.09.014 · Cited by 328
Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma
Lo Coco, F., Ye, B., Lista, F., Corradini, P., Offit, K., Knowles, D., Chaganti, R., & Dalla-Favera, R. (1994) · Blood · doi:10.1182/blood.v83.7.1757.1757 · Cited by 317
Self-citationThe BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT
Huynh, K. D., & Bardwell, V. J. (1998) · Oncogene · doi:10.1038/sj.onc.1202197 · Cited by 305
Ding, B. B., Yu, J. J., Yu, R. Y.-L., Mendez, L. M., Shaknovich, R., Zhang, Y., Cattoretti, G., & Ye, B. H. (2008) · Blood · doi:10.1182/blood-2007-04-087734 · Cited by 298
Pasqualucci, L., Migliazza, A., Basso, K., Houldsworth, J., Chaganti, R. S. K., & Dalla-Favera, R. (2003) · Blood · doi:10.1182/blood-2002-11-3387 · Cited by 295
Self-citationFBXO11 targets BCL6 for degradation and is inactivated in diffuse large B-cell lymphomas
Duan, S., Cermak, L., Pagan, J. K., Rossi, M., Martinengo, C., di Celle, P. F., Chapuy, B., Shipp, M., Chiarle, R., & Pagano, M. (2012) · Nature · doi:10.1038/nature10688 · Cited by 295
Polo, J. M., Dell'Oso, T., Ranuncolo, S. M., Cerchietti, L., Beck, D., Da Silva, G. F., Prive, G. G., Licht, J. D., & Melnick, A. (2004) · Nature Medicine · doi:10.1038/nm1134 · Cited by 291
Niu, H., Ye, B. H., & Dalla-Favera, R. (1998) · Genes & Development · doi:10.1101/gad.12.13.1953 · Cited by 291
Self-citationA Small-Molecule Inhibitor of BCL6 Kills DLBCL Cells In Vitro and In Vivo
Cerchietti, L. C., Ghetu, A. F., Zhu, X., Da Silva, G. F., Zhong, S., Matthews, M., Bunting, K. L., Polo, J. M., Farès, C., Arrowsmith, C. H., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.050 · Cited by 288
Baron, B. W., Nucifora, G., McCabe, N., Espinosa, R., Le Beau, M. M., & McKeithan, T. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.5262 · Cited by 287
Tumors in Rubinstein‐Taybi syndrome
Miller, R. W., & Rubinstein, J. H. (1995) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320560125 · Cited by 283
Mechanism of SMRT Corepressor Recruitment by the BCL6 BTB Domain
Ahmad, K. F., Melnick, A., Lax, S., Bouchard, D., Liu, J., Kiang, C.-L., Mayer, S., Takahashi, S., Licht, J. D., & Privé, G. G. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00454-4 · Cited by 283
The impact of acetylation and deacetylation on the p53 pathway
Brooks, C. L., & Gu, W. (2011) · Protein & Cell · doi:10.1007/s13238-011-1063-9 · Cited by 280
Ranuncolo, S. M., Polo, J. M., Dierov, J., Singer, M., Kuo, T., Greally, J., Green, R., Carroll, M., & Melnick, A. (2007) · Nature Immunology · doi:10.1038/ni1478 · Cited by 278
Ye, B. H., Chaganti, S., Chang, C. C., Niu, H., Corradini, P., Chaganti, R. S., & Dalla-Favera, R. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00311.x · Cited by 277
Self-citationBCL-6 expression during B-cell activation
Allman, D., Jain, A., Dent, A., Maile, R., Selvaggi, T., Kehry, M., & Staudt, L. (1996) · Blood · doi:10.1182/blood.v87.12.5257.bloodjournal87125257 · Cited by 252
Basso, K., Saito, M., Sumazin, P., Margolin, A. A., Wang, K., Lim, W.-K., Kitagawa, Y., Schneider, C., Alvarez, M. J., Califano, A., et al. (2010) · Blood · doi:10.1182/blood-2009-06-227017 · Cited by 246
Self-citationYe, B. H., Rao, P. H., Chaganti, R. S. K., & Dalla‐Favera, R. (1993) · PubMed · Cited by 243
Self-citationCi, W., Polo, J. M., Cerchietti, L., Shaknovich, R., Wang, L., Yang, S. N., Ye, K., Farinha, P., Horsman, D. E., Gascoyne, R. D., et al. (2009) · Blood · doi:10.1182/blood-2008-12-193037 · Cited by 239
Iqbal, J., Greiner, T. C., Patel, K., Dave, B. J., Smith, L., Ji, J., Wright, G., Sanger, W. G., Pickering, D. L., Jain, S., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404856 · Cited by 217
Kirschbaum, M., Frankel, P., Popplewell, L., Zain, J., Delioukina, M., Pullarkat, V., Matsuoka, D., Pulone, B., Rotter, A. J., Espinoza-Delgado, I., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.1398 · Cited by 213
BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma
Saito, M., Novak, U., Piovan, E., Basso, K., Sumazin, P., Schneider, C., Crespo, M., Shen, Q., Bhagat, G., Califano, A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903854106 · Cited by 197
Self-citationLee, C. H., Melchers, M., Wang, H., Torrey, T. A., Slota, R., Qi, C.-F., Kim, J. Y., Lugar, P., Kong, H. J., Farrington, L., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051450 · Cited by 187
A peptomimetic inhibitor of BCL6 with potent antilymphoma effects in vitro and in vivo
Cerchietti, L. C., Yang, S. N., Shaknovich, R., Hatzi, K., Polo, J. M., Chadburn, A., Dowdy, S. F., & Melnick, A. (2009) · Blood · doi:10.1182/blood-2008-07-168773 · Cited by 183
Tracking CD40 signaling during germinal center development
Basso, K., Klein, U., Niu, H., Stolovitzky, G. A., Tu, Y., Califano, A., Cattoretti, G., & Dalla-Favera, R. (2004) · Blood · doi:10.1182/blood-2003-12-4291 · Cited by 182
Self-citationClass II Histone Deacetylases Are Directly Recruited by BCL6 Transcriptional Repressor
Lemercier, C., Brocard, M.-P., Puvion-Dutilleul, F., Kao, H.-Y., Albagli, O., & Khochbin, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201736200 · Cited by 172
Parekh, S. S., Polo, J. M., Shaknovich, R., Juszczyński, P., Lev, P. R., Ranuncolo, S. M., Yin, Y., Klein, U., Cattoretti, G., Favera, R. D., et al. (2007) · Blood · doi:10.1182/blood-2007-01-069575 · Cited by 166
Cerchietti, L. C., Lopes, E. C., Yang, S. N., Hatzi, K., Bunting, K. L., Tsikitas, L. A., Mallik, A., Robles, A. I., Walling, J., Varticovski, L., et al. (2009) · Nature Medicine · doi:10.1038/nm.2059 · Cited by 161
Wong, C. W., & Privalsky, M. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.42.27695 · Cited by 156
Critical role for Stat3 in T-dependent terminal differentiation of IgG B cells
Fornek, J. L., Tygrett, L. T., Waldschmidt, T. J., Poli, V., Rickert, R. C., & Kansas, G. S. (2006) · Blood · doi:10.1182/blood-2005-07-2871 · Cited by 148 · cited 1×
“These pathways have been suggested to play a role in plasma cell differentiation, as shown by the association of STAT3 deficiency with a defect in generation of plasma cells that produce IgG subclasses (49).”
BackgroundB cell–intrinsic TLR signals amplify but are not required for humoral immunity
Meyer‐Bahlburg, A., Khim, S., & Rawlings, D. J. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20071250 · Cited by 147
Cattoretti, G., Shaknovich, R., Smith, P. M., Jäck, H., Murty, V. V. V. S., & Alobeid, B. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.6930 · Cited by 139
Polo, J. M., Juszczyński, P., Monti, S., Cerchietti, L. C. A., Ye, K. Q., Greally, J. M., Shipp, M. A., & Melnick, A. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611399104 · Cited by 137
Cerchietti, L. C. A., Hatzi, K., Caldas-Lopes, E., Yang, S. N., Figueroa, M. E., Morin, R. D., Hirst, M., Mendez, L., Shaknovich, R., Cole, P. A., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42869 · Cited by 121
Chen, W., Iida, S., Louie, D. C., Dalla‐Favera, R., & Chaganti, R. S. K. (1998) · Blood · doi:10.1182/blood.v91.2.603 · Cited by 119
Self-citationBCL6 represses CHEK1 and suppresses DNA damage pathways in normal and malignant B-cells
Ranuncolo, S. M., Polo, J. M., & Melnick, A. (2008) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2008.02.003 · Cited by 116
Wang, X., Li, Z., Naganuma, A., & Ye, B. H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232581199 · Cited by 115
Genotoxic stress regulates expression of the proto-oncogene Bcl6 in germinal center B cells
Phan, R. T., Saito, M., Kitagawa, Y., Means, A. R., & Dalla‐Favera, R. (2007) · Nature Immunology · doi:10.1038/ni1508 · Cited by 111
Self-citationBCL6 Controls the Expression of the B7-1/CD80 Costimulatory Receptor in Germinal Center B Cells
Niu, H., Cattoretti, G., & Dalla‐Favera, R. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021395 · Cited by 103
Self-citationCtBP Is an Essential Corepressor for BCL6 Autoregulation
Mendez, L., Polo, J. M., Yu, J., Krupski, M., Ding, B. B., Melnick, A. M., & Ye, B. H. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01400-07 · Cited by 70
Recognition DNA Sequence of a Novel Putative Transcription Factor, BCL6
Kawamata, N., Takashi, M. I. K. I., Ohashi, K., et al. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2468 · Cited by 65
Alternative translocation breakpoint cluster region 5' to BCL-6 in B-cell non-Hodgkin's lymphoma.
Butler, M. P., Iida, S., Capello, D., Rossi, D., Rao, P. H., Nallasivam, P., Louie, D. C., Chaganti, S. R., Au, T., Gascoyne, R. D., et al. (2002) · PubMed · Cited by 53
Self-citationToward a systems biology approach to investigate cellular networks in normal and malignant B cells
Basso, K. (2009) · Leukemia · doi:10.1038/leu.2009.4 · Cited by 4
Self-citation
Cited by
The generation of antibody-secreting plasma cells
Nutt, S. L., Hodgkin, P. D., Tarlinton, D. M., & Corcoran, L. M. (2015) · Nature Reviews Immunology · doi:10.1038/nri3795 · Cited by 1,454
Dynamics of B cells in germinal centres
De Silva, N. S., & Klein, U. (2015) · Nature Reviews Immunology · doi:10.1038/nri3804 · Cited by 1,084
Zhang, Y., Chen, H., Mo, H., Hu, X., Gao, R., Zhao, Y., Liu, B., Niu, L., Sun, X., Yu, X., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.09.010 · Cited by 783
Chapuy, B., McKeown, M. R., Lin, C. Y., Monti, S., Roemer, M. G. M., Qi, J., Rahl, P. B., Sun, H. H., Yeda, K. T., Doench, J. G., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.11.003 · Cited by 735
“…protein) and BCL6, and additional genes with disproportionally BRD4-loaded enhancers such as PAX5 and IRF8 (Figure 4E), are essential for B-cell fate determination and germinal center formation (Basso and Dalla-Favera, 2012; Klein and Dalla-Favera, 2008; Teitell, 2003; Wang et al., 2008).”
InfluentialMechanisms and function of substrate recruitment by F-box proteins
Skaar, J. R., Pagan, J. K., & Pagano, M. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3582 · Cited by 689
Metadata
- Authors
- Basso, K., & Dalla‐Favera, R.
- Venue
- Immunological Reviews
- Publisher
- Wiley
- Published
- 2012-04-13
- Volume
- 247
- Issue
- 1
- Pages
- 172-183
- ISSN
- 0105-2896 (ISSN-L)
- 1600-065X
- OpenAlex
- W1834505123
- Cited by
- 429
- References
- 81
- FWCI
- 5.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.